Suppr超能文献

脾阻断作为冠状动脉腺苷反应预测因子的研究:在混合 PET/CMR 扫描仪上进行 co-injection 心肌灌注成像时与 13N-氨比较的验证。

Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner.

机构信息

Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich and University Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.

出版信息

J Cardiovasc Magn Reson. 2021 Jan 7;23(1):3. doi: 10.1186/s12968-020-00696-y.

Abstract

BACKGROUND

Inadequate coronary adenosine response is a potential cause for false negative ischemia testing. Recently, the splenic switch-off (SSO) sign has been identified as a promising tool to ascertain the efficacy of adenosine during vasodilator stress cardiovascular magnetic resonance imaging (CMR). We assessed the value of SSO to predict adenosine response, defined as an increase in myocardial blood flow (MBF) during quantitative stress myocardial perfusion 13 N-ammonia positron emission tomography (PET).

METHODS

We prospectively enrolled 64 patients who underwent simultaneous CMR and PET myocardial perfusion imaging on a hybrid PET/CMR scanner with co-injection of gadolinium based contrast agent (GBCA) and 13N-ammonia during rest and adenosine-induced stress. A myocardial flow reserve (MFR) of  > 1.5 or ischemia as assessed by PET were defined as markers for adequate coronary adenosine response. The presence or absence of SSO was visually assessed. The stress-to-rest intensity ratio (SIR) was calculated as the ratio of stress over rest peak signal intensity for splenic tissue. Additionally, the spleen-to-myocardium ratio, defined as the relative change of spleen to myocardial signal, was calculated for stress (SMR) and rest.

RESULTS

Sixty-one (95%) patients were coronary adenosine responders, but SSO was absent in 18 (28%) patients. SIR and SMR were significantly lower in patients with SSO (SIR: 0.56 ± 0.13 vs. 0.93 ± 0.23; p < 0.001 and SMR: 1.09 ± 0.47 vs. 1.68 ± 0.62; p < 0.001). Mean hyperemic and rest MBF were 2.12 ± 0.68 ml/min/g and 0.78 ± 0.26 ml/min/g, respectively. MFR was significantly higher in patients with vs. patients without presence of SSO (3.07 ± 1.03 vs. 2.48 ± 0.96; p = 0.038), but there was only a weak inverse correlation between SMR and MFR (R = -0.378; p = 0.02) as well as between SIR and MFR (R = -0.356; p = 0.004).

CONCLUSIONS

The presence of SSO implies adequate coronary adenosine-induced MBF response. Its absence, however, is not a reliable indicator for failed adenosine-induced coronary vasodilatation.

摘要

背景

腺苷反应不足是导致缺血检测假阴性的一个潜在原因。最近,脾阻断(SSO)征已被确定为一种很有前途的工具,可在血管扩张剂应激心血管磁共振成像(CMR)期间确定腺苷的疗效。我们评估了 SSO 预测腺苷反应的价值,腺苷反应定义为定量应激心肌灌注 13N-氨正电子发射断层扫描(PET)期间心肌血流(MBF)的增加。

方法

我们前瞻性纳入了 64 例患者,这些患者在配备正电子发射断层扫描/CMR 扫描仪的混合 PET/CMR 扫描仪上同时进行 CMR 和 PET 心肌灌注成像,在静息和腺苷诱导应激期间同时注射钆基对比剂(GBCA)和 13N-氨。心肌血流储备(MFR)>1.5 或 PET 评估的缺血被定义为适当的冠状动脉腺苷反应的标志物。通过视觉评估 SSO 的存在或不存在。计算脾组织的应激与静息峰值信号强度比(SIR)作为应激与静息的比值。此外,还计算了应激(SMR)和静息时的脾与心肌信号比,定义为脾与心肌信号的相对变化比,即脾与心肌比。

结果

61 例(95%)患者为冠状动脉腺苷反应者,但 18 例(28%)患者无 SSO。有 SSO 的患者 SIR 和 SMR 明显较低(SIR:0.56±0.13 与 0.93±0.23;p<0.001 和 SMR:1.09±0.47 与 1.68±0.62;p<0.001)。平均充血和静息 MBF 分别为 2.12±0.68ml/min/g 和 0.78±0.26ml/min/g。有 SSO 的患者 MFR 明显高于无 SSO 的患者(3.07±1.03 与 2.48±0.96;p=0.038),但 SMR 与 MFR 之间仅存在弱负相关(R=-0.378;p=0.02),SIR 与 MFR 之间也存在弱负相关(R=-0.356;p=0.004)。

结论

SSO 的存在提示腺苷诱导的 MBF 反应良好。然而,其不存在并不能可靠地指示腺苷诱导的冠状动脉扩张失败。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b271/7789581/de39c9e93213/12968_2020_696_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验